Literature DB >> 7812619

Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action.

J P Hubert1, J C Delumeau, J Glowinski, J Prémont, A Doble.   

Abstract

1. Intracellular calcium levels were measured in cultured cerebellar granule cells of the rat by use of the fluorescent dye, indo-1/AM. 2. Intracellular calcium levels were increased by depolarizing stimuli such as N-methyl-D-aspartate (NMDA) (100 microM), glutamic acid (20 microM), and veratridine (10 microM). This increase was essentially due to entry of external calcium. 3. Riluzole (10 microM) blocked responses to all the depolarizing agents. 4. Riluzole could still block the increase in intracellular calcium evoked by NMDA or glutamic acid when sodium channels were blocked by tetrodotoxin, suggesting that this effect is not mediated by a direct action of riluzole on the voltage-dependent sodium channel. 5. Pretreatment of the cells with pertussis toxin (0.1 micrograms ml-1) did not modify the increases in intracellular calcium evoked by NMDA, glutamic acid or veratridine. 6. In pertussis toxin-treated cells, riluzole could no longer block responses to excitatory amino acids, but still blocked responses to veratridine. 7. It is concluded that riluzole has a dual action on cerebellar granule cells, both blocking voltage-dependent sodium channels and interfering with NMDA receptor-mediated responses via a pertussis toxin-sensitive mechanism. Furthermore, these two processes have been shown to be independent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812619      PMCID: PMC1510058          DOI: 10.1111/j.1476-5381.1994.tb16203.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells.

Authors:  A Doble; J P Hubert; J C Blanchard
Journal:  Neurosci Lett       Date:  1992-06-22       Impact factor: 3.046

2.  2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.

Authors:  J Benavides; J C Camelin; N Mitrani; F Flamand; A Uzan; J J Legrand; C Gueremy; G Le Fur
Journal:  Neuropharmacology       Date:  1985-11       Impact factor: 5.250

3.  Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.

Authors:  C Malgouris; F Bardot; M Daniel; F Pellis; J Rataud; A Uzan; J C Blanchard; P M Laduron
Journal:  J Neurosci       Date:  1989-11       Impact factor: 6.167

4.  2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.

Authors:  J Mizoule; B Meldrum; M Mazadier; M Croucher; C Ollat; A Uzan; J J Legrand; C Gueremy; G Le Fur
Journal:  Neuropharmacology       Date:  1985-08       Impact factor: 5.250

5.  Measurement of CA2+ transients using simultaneous dual-emission microspectrofluorimetry and electrophysiology in individual pituitary cells.

Authors:  P Mollard; N Guerineau; J Audin; B Dufy
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

6.  Synergistic Regulation of Cytosolic Ca2+ Concentration by Adenosine and alpha1-Adrenergic Agonists in Mouse Striatal Astrocytes.

Authors:  Jean C. Delumeau; Martine Tencé; Philippe Marin; Jocelyne Cordier; Jacques Glowinski; Joël Prémont
Journal:  Eur J Neurosci       Date:  1991-06       Impact factor: 3.386

7.  Interactions between Ca2+ mobilizing mechanisms in cultured rat cerebellar granule cells.

Authors:  A J Irving; G L Collingridge; J G Schofield
Journal:  J Physiol       Date:  1992-10       Impact factor: 5.182

Review 8.  Protein kinase C modulation of NMDA currents: an important link for LTP induction.

Authors:  Y Ben-Ari; L Aniksztejn; P Bregestovski
Journal:  Trends Neurosci       Date:  1992-09       Impact factor: 13.837

9.  Selective release of glutamate from cerebellar granule cells differentiating in culture.

Authors:  V Gallo; M T Ciotti; A Coletti; F Aloisi; G Levi
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Pharmacologically distinct glutamate receptors on cerebellar granule cells.

Authors:  J Drejer; T Honoré; E Meier; A Schousboe
Journal:  Life Sci       Date:  1986-06-09       Impact factor: 5.037

View more
  14 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

Review 2.  Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.

Authors:  Jason M Dwyer; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-01-04       Impact factor: 13.382

Review 3.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

4.  Effects of riluzole on electrically evoked neurotransmitter release.

Authors:  T Jehle; J Bauer; E Blauth; A Hummel; M Darstein; T M Freiman; T J Feuerstein
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 5.  Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.

Authors:  H M Bryson; B Fulton; P Benfield
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 6.  Neurotoxins and neurotoxic species implicated in neurodegeneration.

Authors:  Juan Segura Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

7.  Cost-benefit analysis of riluzole for the treatment of amyotrophic lateral sclerosis.

Authors:  G M Ginsberg; B Lev
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

8.  Riluzole is a promising pharmacological inhibitor of bilirubin-induced excitotoxicity in the ventral cochlear nucleus.

Authors:  Guo-Ying Han; Chun-Yan Li; Hai-Bo Shi; Ji-Ping Wang; Kai-Ming Su; Xin-Lu Yin; Shan-Kai Yin
Journal:  CNS Neurosci Ther       Date:  2014-12-12       Impact factor: 5.243

Review 9.  Riluzole in the treatment of mood and anxiety disorders.

Authors:  Christopher Pittenger; Vladimir Coric; Mounira Banasr; Michael Bloch; John H Krystal; Gerard Sanacora
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 10.  NMDA receptors in clinical neurology: excitatory times ahead.

Authors:  Lorraine V Kalia; Suneil K Kalia; Michael W Salter
Journal:  Lancet Neurol       Date:  2008-08       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.